London, United Kingdom

Anna M Randi

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: Imperial College Innovations Limited, The University of Chicago. Active years: 2023.

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2023

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Anna M Randi in Wound Treatment

Introduction

Anna M Randi is an accomplished inventor based in London, GB. She has made significant contributions to the field of wound treatment through her innovative methods and compositions. Her work addresses critical needs in medical science, particularly in the area of healing and recovery.

Latest Patents

Anna M Randi holds a patent for "Methods and compositions for the treatment of wounds." This patent describes peptides and polypeptides that include a growth factor binding domain. The peptides have an amino acid sequence that is at least 80% identical to specific sequences, and they are designed to be less than 300 amino acids in length. This innovation has the potential to enhance wound healing processes significantly.

Career Highlights

Throughout her career, Anna has worked with prestigious institutions such as the University of Chicago and Imperial College Innovations Limited. Her experience in these organizations has allowed her to develop and refine her innovative ideas, contributing to advancements in medical treatments.

Collaborations

Anna has collaborated with notable professionals in her field, including Jeffrey Alan Hubbell and Jun Ishihara. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise.

Conclusion

Anna M Randi's contributions to wound treatment through her innovative patents and collaborations highlight her role as a leading inventor in the medical field. Her work continues to pave the way for advancements in healing technologies.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…